The meshed biological matrix in immediate, definitive breast reconstruction.

Abstract

The aim of this study is to verify the advantages of using a meshed biological matrix (U.I.B.M.-Italian Patent No. 283625) compared to the intact one. A prospective double blind randomized clinical trial with 46 cases of immediate breast reconstruction was performed. The utilization of a meshed biological matrix results in less drainage, reduced need for drains after a few days and a very small percentage rate of seromas and complications, if compared with the utilization of an intact biological matrix.